Medicinal – Page 68

Pathogen Enzyme-Mediated Alkoxyamine Homolysis as a Killing Mechanism of Aspergillus fumigatus

mycolabadmin

Researchers have developed a new type of antifungal drug that uses the fungus’s own enzymes against it. The drug is inactive until it encounters an enzyme produced by Aspergillus fumigatus, where it releases toxic molecules that kill the fungus. Importantly, this approach works against both normal and drug-resistant strains of the fungus, offering hope for treating serious fungal infections that don’t respond to current treatments.

Whole genome sequencing and annotations of Trametes sanguinea ZHSJ

mycolabadmin

Scientists have completely mapped the genetic code of Trametes sanguinea, a medicinal mushroom used in traditional Chinese medicine. They identified over 10,000 genes and analyzed how this mushroom produces compounds that fight tumors, boost immunity, protect the heart, and fight viruses. This genetic map will help researchers understand how to produce these beneficial compounds and develop new medicines from this mushroom.

Evaluation of the combined efficacy of inhibitors of heat shock protein 90 and calcineurin with commonly used antifungals against Aspergillus, Rhizopus, and Fusarium isolates

mycolabadmin

Scientists tested combinations of common antifungal medications with special inhibitor drugs that target fungal stress-response systems. When combined, these drugs worked better together against dangerous mold infections like Aspergillus and Rhizopus, especially those that are resistant to standard treatments. The combinations rarely caused harmful interactions and often enhanced the antifungal effects, suggesting this approach could improve treatment of serious mold infections.

Disseminated subcutaneous sporotrichosis in an immunocompetent patient: A case report and a systematic literature review

mycolabadmin

A 74-year-old man developed multiple infected lumps on his arm, wrist, and finger months after being injured by a tree branch. Doctors identified the infection as sporotrichosis caused by a fungus called Sporothrix schenckii using advanced genetic testing. He was successfully treated with itraconazole tablets for several months and completely recovered. This case is unusual because sporotrichosis typically affects people with weakened immune systems, but this patient had a normal immune system.

Candida auris: Outbreak, surveillance and epidemiological monitoring in Northern Greece

mycolabadmin

A dangerous fungus called Candida auris caused an outbreak in hospitals in Northern Greece starting in October 2022. This fungus is particularly concerning because it is resistant to many commonly used antifungal drugs, especially fluconazole. Researchers monitored and tracked the outbreak across multiple hospitals, finding that all cases belonged to the same genetic type (Clade I) and were treatable with certain alternative antifungal medications. The study emphasizes the importance of careful laboratory surveillance and coordinated infection control measures to prevent further spread of this serious infection.

Sporothrix is neglected among the neglected

mycolabadmin

Sporotrichosis is a fungal infection caused by Sporothrix species that usually affects the skin but can spread to joints, lungs, and eyes. While traditionally spread through plant material during gardening, the disease has increasingly spread between cats and humans through bites and scratches, particularly in South America and other regions. The fungus is developing resistance to common antifungal drugs, and scientists worry climate change could expand where this disease occurs worldwide.

Improving the production of micafungin precursor FR901379 in Coleophoma empetri using heavy-ion irradiation and its mechanism analysis

mycolabadmin

Researchers used heavy-ion radiation to create improved strains of a fungus that produces a precursor to micafungin, an important antifungal drug. The improved strains produced over 3.5 times more of the desired compound than the original strain. By analyzing the genetic changes in these improved strains, the scientists identified which genes were most important for boosting production, helping guide future improvements in manufacturing this life-saving medicine.

Two Cases of Fungal Melanonychia

mycolabadmin

Two patients developed dark pigmentation on their toenails caused by rare combinations of fungal infections. Through laboratory testing and genetic analysis, doctors identified fungi never before known to cause this type of nail discoloration. Both patients were successfully treated with an antifungal medication called efinaconazole, with complete resolution of symptoms within a few months.

The Effect of Natural-Based Formulation (NBF) on the Response of RAW264.7 Macrophages to LPS as an In Vitro Model of Inflammation

mycolabadmin

Researchers tested a natural mixture of five medicinal mushrooms combined with cannabidiol (CBD) on immune cells exposed to bacterial endotoxins. The formulation effectively reduced inflammatory response markers without harming the cells. These findings suggest the mixture could potentially be used to treat inflammatory conditions like asthma and arthritis, though more research is needed.

Soil microorganism colonization influenced the growth and secondary metabolite accumulation of Bletilla striata (Thunb.) Rchb. F.

mycolabadmin

Chinese ground orchid (Bletilla striata) is a medicinal plant whose growth and medicinal compound production depend heavily on soil microorganisms. Researchers found that different soil types harbor different beneficial microbes: sandy loam soils boost plant growth, while sandy clay soils increase medicinal compound concentration. Specific microbes colonize different plant parts, with some promoting growth in roots and tubers, while others enhance the production of militarine, a compound with potential anti-aging and cognitive benefits.

Research Topic: Medicinal